-
公开(公告)号:US12230380B2
公开(公告)日:2025-02-18
申请号:US17651873
申请日:2022-02-21
Applicant: UnitedHealth Group Incorporated
Inventor: Jeffrey Smith , Marissa N. Dent , Louis A. Wedge , Cary R. Shelley , Aliya Mansoor
IPC: G06F18/2431 , G16H20/10
Abstract: Various embodiments of the present invention provide methods, apparatus, systems, computing devices, computing entities, and/or the like for performing predictive data analysis. Certain embodiments of the present invention utilize systems, methods, and computer program products that perform predictive data analysis by using at least one of prospective coverage score determination machine learning models and prospective event-based classification machine learning models.
-
公开(公告)号:US20250054606A1
公开(公告)日:2025-02-13
申请号:US18722998
申请日:2022-12-21
Applicant: UNIVERSITY OF THE RYUKYUS
Inventor: Shogo ISHIUCHI
Abstract: An emotional disorder evaluation system comprising: an acquisition unit configured to acquire image data representing the hippocampus of a subject, and a specification unit configured to identify volume data representing the volume of the right hippocampus-amygdala transition area of the subject in accordance with the image data.
-
公开(公告)号:US12224073B2
公开(公告)日:2025-02-11
申请号:US17666780
申请日:2022-02-08
Applicant: Microsoft Technology Licensing, LLC
Abstract: A method, computer program product, and computing system for: monitoring a meeting between a patient and a medical entity during a telehealth medical encounter; gathering information during the telehealth medical encounter, thus generating gathered encounter information; and rendering an informational window concerning the telehealth medical encounter for review by the patient and/or the medical entity, wherein the informational window is configured to provide supplemental information based, at least in part, upon the gathered encounter information.
-
公开(公告)号:US12224049B2
公开(公告)日:2025-02-11
申请号:US17643363
申请日:2021-12-08
Applicant: Eysz, Inc.
Inventor: Rachel Kuperman , Parth Amin , Bikramjit Sarkar
Abstract: Systems and methods for monitoring and managing neurological diseases and conditions are disclosed herein. In some embodiments, a method for monitoring a patient having a neurological disease or condition includes receiving, from one or more patient monitoring devices, first patient data for a baseline time period. The method can include determining, based on the first patient data, first seizure data and first side effect data during the baseline time period. The method can further include receiving, from the one or more patient monitoring devices, second patient data for a treatment time period, and determining, based on the second patient data, second seizure data and second side effect data during the treatment time period. The method can also include generating a personalized dose-response profile for the patient based on the first and second seizure data and the first and second side effect data.
-
公开(公告)号:US12220559B2
公开(公告)日:2025-02-11
申请号:US18132510
申请日:2023-04-10
Applicant: Medtronic MiniMed, Inc.
Inventor: Michael Robert Mensinger , Sean Saint
Abstract: Provided is a system for delivering and recording a dose of a medicament to a patient. Also provided is a method of administering a medicament to a patient. Additionally provided is a method of tracking usage of a medicament by a patient through a pen.
-
6.
公开(公告)号:US20250046417A1
公开(公告)日:2025-02-06
申请号:US18797957
申请日:2024-08-08
Applicant: Acorai AB
Inventor: Filip Ludwig Peters
Abstract: Systems and methods for creating personalized medicines for treating heart failure and heart disease that can capture non-invasive intracardiac pressure signals of the user through a micro-electro-mechanical sensor configured to a computing device. Bio-sample user data can also be captured through a bio-sample module. Other components can capture demographic data pertaining to the user. The user's Patient Health Record (PHR) data is captured through a PHR module. The system uses the processed data to create one or more personalized medicines for heart failure and heart disease through a machine learning module which can then be presented on a computing device user interface.
-
公开(公告)号:US20250037879A1
公开(公告)日:2025-01-30
申请号:US18696945
申请日:2022-09-29
Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor: Mohammad Soheilypour , Mohammad Mofrad
Abstract: Methods and systems are provided for design, improvement, optimization, or personalization of microbiome therapeutics for various diseases. In one embodiment, a method comprises identifying a plurality of microbiome features associated with a disease, building a plurality of simulations by modeling the interactions between a plurality of microbial consortia with a plurality of microbiome samples; predicting one or more microbial consortia that improve the plurality of microbiome features associated with a disease from the plurality of simulations; and optimizing composition of one or more microbial consortia that further improve the plurality of microbiome features associated with a disease from the plurality of simulations or personalizing composition of a microbial consortia according to a patient's baseline microbiome to improve the plurality of microbiome features associated with a disease. In this way, effective microbial consortia for a variety of diseases may be reliably predicted in a high-throughput fashion.
-
公开(公告)号:US20250037868A1
公开(公告)日:2025-01-30
申请号:US18786397
申请日:2024-07-26
Applicant: Picture Health, Inc.
Inventor: Haojia Li , Nathaniel Braman , Anant Madabhushi
Abstract: A machine learning system makes medical predictions based, at least in part, on pathomic features indicating collagen fiber organization extracted from pathology images that include lesions. The pathomic features are extracted from pathology images. The pathology images may be routine clinical images gathered in the course of diagnosis and treatment, such as hematoxylin and eosin (H&E)-stained whole slide images (WSIs) of tissue. The medical predictions may concern, e.g., the diagnosis, prognosis, genotype, or phenotype of a lesion, and may include disease-free survival (DFS) and overall survival (OS) of patients known or suspected of having malignant lesions. Methods for training a machine model to make, and for making, such predictions are also disclosed.
-
公开(公告)号:US12211602B2
公开(公告)日:2025-01-28
申请号:US18512503
申请日:2023-11-17
Applicant: Express Scripts Strategic Development, Inc.
Inventor: Susan E. Anselmi , Alexi E. Makarkin , Samuel Affare , John W. Cooper, IV , Jeffrey Whitworth
IPC: G16H20/10 , G06Q10/0832 , G06Q50/22
Abstract: Methods and systems for classifying and editing insurance claims records are described. In one embodiment, a method, which can be performed by a processor, includes identifying that a first prescription drug prescribed to a first patient, identifying a first date and a second date related to the first prescription, the second date occurring after the first date, both the first and second dates depending on a previous fill of the first prescription drug, identifying, at the processor, a third date associated with a second prescription, comparing, at the processor, the third date to the first and second dates to determine whether the third date occurs after the first date and before the second date, and filling and dispensing the first prescription drug and the second prescription drug on the same dispense date when the third date occurs after the first date and before the second date.
-
公开(公告)号:US20250029700A1
公开(公告)日:2025-01-23
申请号:US18906602
申请日:2024-10-04
Applicant: Mark Lamoncha
Inventor: Mark Lamoncha
Abstract: Systems and methods for providing virtual pharmacy consultations are disclosed. A prescription database includes unique patient identifiers and associated prescriptions, each associated with a pharmacist identifier. Requests for virtual pharmacist consultations are received from the patient systems, each identifying one of the prescriptions. For each of the requests, the pharmacist identifier associated with the prescription is identified, and an electronic communications link is established between the patient system and a respective one of pharmacist systems for a telecommunications session.
-
-
-
-
-
-
-
-
-